Anesthesia for Parturient with Human Immunodeficiency Virus

  • Hasan Kutluk PampalEmail author
  • Gökçen Emmez


Modern treatment regimens prolong lives and improve quality of life of human immunodeficiency virus (HIV)-infected patients. Many anesthesiologists encounter HIV-infected parturient in their daily practice at the childbearing age. Both the effects of pregnancy and HIV infection may complicate anesthetic and obstetrical interventions. Therefore, anesthesiologists caring for HIV-infected parturient should have a basic knowledge on the clinical manifestation, organ involvement and treatment of the disease, and drug interactions and transmission of the virus to child and healthcare workers. It is essential to have this knowledge to perform a safe anesthetic management plan for the parturient infected with HIV.


HIV Pregnancy General anesthesia Spinal anesthesia Epidural anesthesia Obstetric management Immunosuppression 


  1. 1.
    Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981;305:1425–31.CrossRefGoogle Scholar
  2. 2.
    Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868–71.CrossRefGoogle Scholar
  3. 3.
    Hughes SC. AIDS: the focus turns to women. Int J Obstet Anesth. 1993;2:1–2.CrossRefGoogle Scholar
  4. 4.
  5. 5.
    Hignett R, Fernando R. Anesthesia for the pregnant HIV patient. Anesthesiol Clin. 2008;26:127–43.CrossRefGoogle Scholar
  6. 6.
    Bajwa SJS, Kulshrestha A. The potential anesthetic threats, challenges and intensive care considerations in patients with HIV infection. J Pharm Bioallied Sci. 2013;5:10–6. Scholar
  7. 7.
    HIV testing. Accessed 20 Feb 2018.
  8. 8.
    Kuczkowski KM. Human immunodeficiency virus in the parturient. J Clin Anesth. 2003;15:224–33.CrossRefGoogle Scholar
  9. 9.
    Wlody DJ. Human immunodeficiency virus. In: Chestnut DH, Wong CA, Tsen LC, Kee WDN, Beilin Y, Mhyre JM, Nathan N, editors. Chestnut’s obstetric anesthesia: principles and practice E-book. Amsterdam: Elsevier Health Sciences; 2014.Google Scholar
  10. 10.
    Ntusi N, O’Dwyer E, Dorrell L, Wainwright E, Piechnik S, Clutton G, et al. HIV-1-related cardiovascular disease is associated with chronic inflammation, frequent pericardial effusions, and probable myocardial edema. Circ Cardiovasc Imaging. 2016;9:e004430.CrossRefGoogle Scholar
  11. 11.
    Conte AH. Infectious disease. In: Hines RL, Marschall KE, editors. Stoelting’s anesthesia and co-existing disease. 7th ed. Philadelphia: Elsevier; 2018.Google Scholar
  12. 12.
    Prout J, Agarwal B. Anaesthesia and critical care for patients with HIV infection. Contin Educ Anesth Crit Care Pain. 2005;5:153–6.CrossRefGoogle Scholar
  13. 13.
    Denning DW, Anderson J, Rudge P, Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus. Br Med J (Clin Res Ed). 1987;294:143–4.CrossRefGoogle Scholar
  14. 14.
    Evron S, Glezerman M, Harow E, Sadan O, Ezri T. Human immunodeficiency virus: anesthetic and obstetric considerations. Anesth Analg. 2004;98:503–11.CrossRefGoogle Scholar
  15. 15.
    Leelanukrom R. Anaesthetic considerations of the HIV-infected patients. Curr Opin Anaesthesiol. 2009;22:412–8.CrossRefGoogle Scholar
  16. 16.
    Vishnu P, Aboulafia DM. Haematological manifestations of human immune deficiency virus infection. Br J Haematol. 2015;171:695–709.CrossRefGoogle Scholar
  17. 17.
    Eledrisi MS, Verghese AC. Adrenal insufficiency in HIV infection: a review and recommendations. Am J Med Sci. 2001;321:137–44.CrossRefGoogle Scholar
  18. 18.
    Lo JC, Schambelan M. Adrenal, gonadal, and thyroid disorders. In: Dolin R, Masur H, Saag MS, editors. AIDS therapy. 3rd ed. St. Louis: Churchill Livingstone; 2008.Google Scholar
  19. 19.
    Caton D. Cesarean delivery. In: Chestnut DH, Wong CA, Tsen LC, Kee WDN, Beilin Y, Mhyre JM, Nathan N, editors. Chestnut’s obstetric anesthesia: principles and practice. 5th ed. Philadelphia: Elsevier Saunders; 2014.Google Scholar
  20. 20.
    García F, Niebla G, Romeu J, Vidal C, Plana M, Ortega M, et al. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication. AIDS. 1999;13:1491–6.CrossRefGoogle Scholar
  21. 21.
    Hughes SC, Dailey PA, Landers D, Dattel BJ, Crombleholme WR, Johnson JL. Parturients infected with human immunodeficiency virus and regional anesthesia. Clinical and immunologic response. Anesthesiology. 1995;82:32–7.CrossRefGoogle Scholar
  22. 22.
    Avidan MS, Groves P, Blott M, Welch J, Leung T, Pozniak A. Low complication rate associated with cesarean section under spinal anesthesia for HIV-1-infected women on antiretroviral therapy. Anesthesiology. 2002;97:320–4.CrossRefGoogle Scholar
  23. 23.
    Cruz FF, Rocco PR, Pelosi P. Anti-inflammatory properties of anesthetic agents. Crit Care. 2017;21:67.CrossRefGoogle Scholar
  24. 24.
    Barnett MA, Learmonth RP, Pihl E, Wood EC. T helper lymphocyte depression in early human pregnancy. J Reprod Immunol. 1983;5:55–7.CrossRefGoogle Scholar
  25. 25.
    Gershon RY, Manning-Williams D. Anesthesia and the HIV infected parturient: a retrospective study. Int J Obstet Anesth. 1997;6:76–81.CrossRefGoogle Scholar
  26. 26.
    Katz D, Beilin Y. Review of the alternatives to epidural blood patch for treatment of postdural puncture headache in the parturient. Anesth Analg. 2017;124:1219–28.CrossRefGoogle Scholar
  27. 27.
    Gunaydin B, Acar M, Emmez G, Akcali D, Tokgoz N. Epidural patch with autologous platelet rich plasma: a novel approach. J Anesth. 2017;31:907–10.CrossRefGoogle Scholar
  28. 28.
    Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS. 2008;22:973–81.CrossRefGoogle Scholar
  29. 29.
    European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458–65.CrossRefGoogle Scholar
  30. 30.
    Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, et al. Benefits and risks of antiretroviral therapy for perinatal HIV prevention. N Engl J Med. 2016;375:1726–37.CrossRefGoogle Scholar
  31. 31.
    Townsend CL, Byrne L, Cortina-Borja M, Thorne C, de Ruiter A, Lyall H, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011. AIDS. 2014;28:1049–57.CrossRefGoogle Scholar
  32. 32.
    Hoffman RM, Black V, Technau K, van der Merwe KJ, Currier J, Coovadia A, et al. Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2010;54:35–41.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Tubiana R, Le Chenadec J, Rouzioux C, Mandelbrot L, Hamrene K, Dollfus C, et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1). Clin Infect Dis. 2010;50:585–96.CrossRefGoogle Scholar
  34. 34.
    Menéndez-Arias L. Targeting HIV: antiretroviral therapy and development of drug resistance. Trends Pharmacol Sci. 2002;23:381–8.CrossRefGoogle Scholar
  35. 35.
    de Maat MM, Ekhart GC, Huitema AD, et al. Drug interactions between antiretroviral drugs and comedicated agents. Clin Pharmacokinet. 2003;42:223–82.CrossRefGoogle Scholar
  36. 36.
    Schulenburg F, Le Roux PJ. Antiretroviral therapy and anaesthesia. SAJAA. 2008;14:31–8.Google Scholar
  37. 37.
    Piscitelli SC, Gallicano KD. Interactions among drugs for HIV and opportunistic infections. N Engl J Med. 2001;344:984–96.CrossRefGoogle Scholar
  38. 38.
    Coates TJ, Collins J. Preventing HIV infection. Sci Am. 1998;279:96–7.CrossRefGoogle Scholar
  39. 39.
    American Society of Anesthesiology subcommittee on infection control policy recommendations for infection control for the practice of anesthesiology. Accessed 20 Feb 2018.
  40. 40.
    Bricout F, Moraillon A, Sonntag P, Hoerner P, Blackwelder W, Plotkin S. Virus-inhibiting surgical glove to reduce the risk of infection by enveloped viruses. J Med Virol. 2003;69:538–45.CrossRefGoogle Scholar
  41. 41.
    Baluch A, Maass H, Rivera C, Gautam A, Kaye AD, Frost EA. Current perioperative management of the patient with HIV. Middle East J Anaesthesiol. 2009;20:167–77.PubMedGoogle Scholar
  42. 42.
    Diprose P, Deakin CD, Smedley J. Ignorance of post-exposure prophylaxis guidelines following HIV needlestick injury may increase the risk of seroconversion. Br J Anaesth. 2000;84:767–70.CrossRefGoogle Scholar
  43. 43.
    Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS, US Public Health Service. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. 2005;54:1–17.PubMedGoogle Scholar
  44. 44.
    Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Accessed 20 Feb 2018.
  45. 45.
    Parthasarathy S, Ravishankar M. HIV and anaesthesia. Indian J Anaesth. 2007;51:91–9.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Gazi University Faculty of Medicine, Department of AnesthesiaAnkaraTurkey

Personalised recommendations